endocrinology.org/press/pre...
Hurrah!
This is in response to that paper that came out a few months ago I think it was saying that those with subclinical hypo didn’t benefit from treatment. Looks like thankfully it isn’t just us that has doubts about the study.
They make specific reference to the TSH of less than 20 that was concerning for some of us.
Apologies if this has been posted about already but I couldn’t find a post.